$NAVINFLUOR Navin Fluorine International Ltd (NFIL) is in focus today (6 Aug 2026)

Navin Fluorine International Ltd (NFIL) is in focus today (6 Aug 2026) after posting weak Q1 FY27 results and announcing a leadership transition. The stock slipped nearly 8 % intraday as margins contracted sharply due to higher raw‑material costs and delayed commissioning of the new Dahej plant. 📊 Q1 FY27 Financial Highlights Metric Q1 FY27 Q4 FY26 Change (%) Commentary Revenue ₹1,278 cr ₹1,345 cr ↓ 5 % Lower specialty‑chemicals volumes EBITDA ₹223 cr ₹312 cr ↓ 28 % Cost pressure from fluorochemicals Net Profit ₹118 cr ₹186 cr ↓ 36 % Weak margins and higher depreciation EBITDA Margin 17.4 % 23.2 % ↓ 5.8 pts Sharp contraction EPS ₹12.10 ₹19.10 ↓ 36.6 % Reflects earnings decline 🧪 Operational & Strategic Updates Dahej Plant Delay: Commissioning of the new HPP fluorochemicals unit pushed to Q2 FY27 due to equipment calibration issues. Leadership Change: Mr. Radhesh Welling stepped down as MD & CEO; Mr. Sanjay Kumar Singh (ex‑Tata Chemicals) appointed interim CEO. Capex Outlook: ₹1,200 cr investment over FY27–FY28 for specialty fluorides and battery‑chemicals expansion. Export Mix: US and EU contribute > 60 % of revenue; demand remains steady in pharma intermediates. 📈 Market Reaction NSE: ₹3,412 (−7.85 %) BSE: ₹3,405 (−8.02 %) 52‑Week Range: ₹2,980 – ₹4,820 Trend: Short‑term bearish; analysts expect recovery post‑Dahej commissioning. 🧭 Analyst View Motilal Oswal: “Maintain Buy; target ₹4,200 — short‑term pain, long‑term gain.” ICICI Direct: “Earnings miss; margin recovery expected from Q3 FY27.” Nomura: “Leadership transition adds uncertainty; watch execution.” ⚠️ Risks Delay in Dahej plant ramp‑up. Volatile fluorochemical prices. Leadership transition impact on project execution.